Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06240702
Other study ID # NEU-SSHMYO-FP-MC-01
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 20, 2024
Est. completion date January 31, 2025

Study information

Verified date February 2024
Source Necmettin Erbakan University
Contact Muammer Corum, M.Sc.
Phone 0905433781877
Email muammercorum@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study was to investigate the effects of phase I and early phase II rehabilitation with telerehabilitation method and sleep hygiene training on physical capacity, cardiac functions, anxiety level, quality of life and sleep quality in patients undergoing coronary artery bypass graft surgery.


Description:

Coronary artery disease is one of the most important diseases affecting quality of life in recent years. Coronary artery bypass graft surgery (CABGC), one of the methods used in the treatment of this disease, is widely accepted as a common operation. However, both the surgical intervention and the cardiac and pulmonary complications caused by coronary artery disease, such as decreased physical capacity, decreased quality of life and sleep quality, and restriction in functional activities make it difficult to return to pre-disease level. Today, it is a scientific fact that cardiac and pulmonary rehabilitation applied at the earliest period following surgical treatment reduces the risk of mortality and morbidity, prevents complications and facilitates return to daily life. In fact, it is now a necessity to evaluate and treat patients comprehensively in many aspects such as nutrition, sleep quality and psychological status with a holistic approach. Today, applications that bring together healthcare personnel and patients in a virtual environment such as telemedicine, telerehabilitation and mobile-health, which have been widely used in different medical and health fields, especially after the coronavirus-19 pandemic, have gained importance. Telerehabilitation has advantages in different fields such as neurological, orthopedic, cardiac and pulmonary rehabilitation, such as the ability of the physiotherapist to follow the patient remotely, to apply the rehabilitation program, and to be accessible at any time. In addition, it is stated in the literature that it has mitigating effects on the patient's dependency and health costs, such as eliminating the need for the patient to travel to the center and reducing the need for caregivers. When the literature is examined, it is seen that there are few cardiac and pulmonary rehabilitation applied with telerehabilitation method in the postoperative period in coronary artery bypass graft surgery patients. In addition, there is no study in the literature examining the effect of sleep hygiene training in addition to telerehabilitation on these patients. Therefore, this study aimed to contribute to the literature as an original study by examining the effects of cardiopulmonary rehabilitation and sleep hygiene training applied for 4 weeks with the telerehabilitation method, which is a current approach, on patients who underwent coronary artery bypass graft surgery.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date January 31, 2025
Est. primary completion date August 20, 2024
Accepts healthy volunteers No
Gender All
Age group 45 Years to 75 Years
Eligibility Inclusion Criteria: - Participants who are class 2-3 according to the New York Heart Association (NYHA) - Participants had an ejection fraction >40% - If the participant has had a myocardial infarction (MI), 7 days have passed since the MI - Low-medium risk group patients as a result of Euroscore evaluation (0-2 low risk, 3-5 medium risk, 6< high) - Patients with adequate cognition-perception level (Mini mental test score of 24 and above) - Individuals who are not diagnosed with sleep disorders for any reason - Having the knowledge to make video calls with a smart phone - Declaring that you wish to participate in the study with written consent Exclusion Criteria: - Aneurysm history - Patients with advanced left ventricular dyskinesia - Patients with neurological orthopedic comorbid diseases - Presence of any defect in the rib cage - Patients with Chronic Obstructive Pulmonary Disease (COPD) - Patients hospitalized for a long time (6 months and more)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Telerehabilitation Group
Unlike the control group, the experimental group will be given a phase II telerehabilitation program and sleep hygiene training for 3 weeks after discharge. Within the scope of the Phase II telerehabilitation program, breathing exercises and calisthenic exercises will be performed at increasing intensity according to the patient's tolerance, 3 days a week for 3 weeks. In addition, walking training will be continued over increasing distances. In addition, it will be aimed to increase sleep quality by giving a sleep hygiene education brochure to the patients in the experimental group. During the sessions, the vital signs and clinical status of the patients will be monitored according to the severity level determined by the finger pulse oximeter device, digital blood pressure monitor, perceived difficulty level (Borg Scale) and maximum heart rate. In addition, patients will be kept in a diary to monitor their compliance with the treatment program.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Necmettin Erbakan University

Outcome

Type Measure Description Time frame Safety issue
Primary 6 minute walk test (6MWT) The test is performed in a closed area, on a flat surface 30 meters long (every 3 meters is marked), under the supervision of a physiotherapist. Dyspnea and fatigue of the patients are questioned during the 6MWT and the values before and after the test are recorded. At the end of 6 minutes, the total distance walked by the patient is recorded in meters. Studies have shown that a 6-minute walking distance of less than 350 meters is a predictor of mortality in cardiopulmonary diseases. four weeks
Primary Duke Activity Status Scale This 12-question index helps to calculate the metabolic equivalent of task (MET) used in daily life. 1 MET represents the resting Oxygen consumption of a 40-year-old 70 kg person at rest, which is normally 3.5 ml/kg/min. According to this index; self-care, eating, dressing, going to the toilet, short walks inside the house, short walks outside, light housework, between 1-4 METs; climbing hills or stairs, fast walking, short jogging, heavier work at home, light sports, between 4-10 METs; Heavy sports such as swimming, tennis are evaluated above 10 METs. The approximate values obtained according to the answers to the questions asked are classified as follows; Excellent if >7 MET 4-7 MET is Moderate <4 MET indicates a poor or uncertain prognosis. four weeks
Primary State Trait Anxiety Inventory The Turkish version of the State Trait Anxiety Inventory (STAI) will be used to assess the anxiety level of the subjects. The STAI consists of 2 parts, the state anxiety scale and the trait anxiety scale, and a total of 40 questions. When answering the state anxiety scale, patients are asked to select one of the options 'not at all', 'a little', 'a lot' and 'completely' according to the severity of the feelings, thoughts and behaviors expressed by the items; when answering the trait anxiety scale, patients are asked to mark one of the options 'almost never', 'sometimes', 'most of the time' and 'almost always' according to the frequency of the feelings, thoughts and behaviors expressed by the items. High scores indicate a high level of anxiety. Turkish validity and reliability studies have been conducted. four weeks
Primary Pittsburgh Sleep Quality Index (PSQI) PSQI was adapted into Turkish by Agargun et al. (1996). PSQI evaluates sleep quality in the last month. 19 of the total 24 questions included in PSQI are self-report questions. 5 questions are answered by the spouse or a roommate. The last 5 questions mentioned are used only for clinical information and are not included in the scoring. The 18 items included in the scoring are grouped into 7 component scores. Some of the components are specified with a single item, while others are obtained by grouping several items. Each item is evaluated on a scale of 0-3 points. The sum of the 7 component scores gives the total PSQI score. The total score has a value between 0-21. A high total score indicates poor sleep quality. four weeks
Secondary Echocardiography The term echocardiography covers all imaging techniques in which the heart is examined with ultrasound, such as pulsed and continuous wave Doppler, color Doppler and tissue Doppler imaging (TDI: tissue doppler imaging). Echocardiography is an easily accessible, non-invasive, rapid and safe method that provides comprehensive information on cardiac anatomy (volumes, geometry, mass), wall motion and valve function. four weeks
Secondary Left Ventricular Dysfunction Scale (LVD-36) The Left Ventricular Dysfunction (LVD-36) Scale was developed by O'Leary and Jones (2000) to measure the effect of left ventricular dysfunction on daily life and well-being in patients with heart failure. This scale; It consists of a total of 36 statements asked to determine the problems caused by heart disease. Statements are presented to patients with two options: true or false. The correct answers given are added up and the total number of correct answers is expressed as a percentage. Scores from the scale are between "0-100", with "100 points" taken from the scale being considered the worst score and "0 points" being considered the best score. As the score of the scale increases, the quality of life decreases. The Turkish validity and reliability study of the LVD-36 scale was conducted by Özer and Argon (2005). four weeks
Secondary Minnesota Living With Heart Failure Questionnaire It is a quality of life survey consisting of 21 questions and two dimensions (physical and emotional sub-dimensions) specific to Heart Failure patients. It was designed by Thomas Rector in 1984 to measure the impact of heart failure and its treatment on an individual's quality of life. The survey was prepared in Likert type. The survey assesses the impact of common physical symptoms such as shortness of breath, fatigue, peripheral edema, symptoms of anxiety and depression. In addition, it aims to measure the effects of physical and social functioning in heart failure. The lowest score that can be obtained from the scale is 5 and the highest score is 105. The Turkish adaptation was made by Uzunhasanoglu in 2013. four weeks
Secondary Modified Medical Research Council Dyspnea Scale The scale used to evaluate patients' shortness of breath classifies it from stage 1 to stage 5 to determine the severity of shortness of breath. four weeks
Secondary Hand Grip Strength Assessment Upper extremity muscle strength will be evaluated with a hand dynamometer. It has been reported that hand grip strength is not only correlated with upper extremity muscle strength, but also with general body muscle strength and pulmonary muscle strength. Test; It will be made in the sitting position, which is the standard position recommended by the American Association of Hand Therapists, with the shoulder in adduction and neutral rotation, the elbow in 90° flexion, the forearm in middle rotation, and the wrist in neutral. Three measurements will be made, the average will be taken and recorded as kg/F. In addition, pinch grip strength will be measured in the same way with a pinch meter type dynamometer. four weeks
Secondary 30-second sit-to-stand test This test reflects the strength of the lower extremities. The individual sits on the middle part of the chair, which has no armrests and a sitting height of 43.18 cm, with his back upright and straight, his arms crossed in front, and his feet flat on the floor. It stands up and sits down fully upon the start command. Count the number of times he stands up fully in 30 seconds. four weeks
Secondary Body Weight Participants' body weight will be recorded as demographic data in kg unit. four weeks
Secondary Body height The height of the participants will be recorded as demographic data in meters unit. four weeks
Secondary Body Mass Index Participants' body mass index will be recorded as demographic data in kg/m² unit. four weeks
Secondary Heart Rate Participants' heart rates before and after the intervention will be recorded in beats/minute. four weeks
Secondary Blood Pressure The blood pressure of the participants before and after the intervention will be recorded in mmHg. four weeks
Secondary Respiratory Frequency The respiratory frequency of the participants before and after the intervention will be recorded as breaths/minute. four weeks
Secondary Oxygen Saturation The oxygen saturation of the participants before and after the intervention will be recorded as SaO2(%). four weeks
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Coronary De Novo Lesions N/A